ArticleGynecologic oncology reports2018
Cervical cancer in women over 65: An analysis of screening.
Article in Gynecologic oncology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06431724 (A Prospective Analysis of Adherence to National Cervical Cancer Screening Recommendations in Women Age >65), which is not on this map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Prospective Analysis of Adherence to National Cervical Cancer Screening Recommendations in Women Age >65
Who cites it
14 citing papers in PubMed.
- Value of a catch-up HPV test in women aged 65 and above: A Danish population-based nonrandomized intervention study.PLoS medicine · 2023Trial
- Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial.The British journal of general practice : the journal of the Royal College of General Practitioners · 2022Trial
- Preoperative Cognitive Function and Physical Frailty Predict Decision Satisfaction and Postoperative Adherence in Older Gynecologic Oncology Patients: A Prospective Observational Study.Current oncology (Toronto, Ont.) · 2026Observational
- Visual inspection with acetic acid and colposcopy: screening of cervical cancer in resource-limited healthcare settings.Frontiers in global women's health · 2025Article
- Tissue-resident immune cells in cervical cancer: emerging roles and therapeutic implications.Frontiers in immunology · 2025Review
- Article
- Targeting inflammation as cancer therapy.Journal of hematology & oncology · 2024Review
- Cervical Cancer Stage at Diagnosis and Survival among Women ≥65 Years in California.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023Article
- Understanding cervical cancer after the age of routine screening: Characteristics of cases, treatment, and survival in the United States.Gynecologic oncology · 2022Article
- Inhibition of HMGB1/RAGE axis suppressed the lipopolysaccharide (LPS)-induced vicious transformation of cervical epithelial cells.Bioengineered · 2021Article
- It's time to re-evaluate cervical Cancer screening after age 65.Gynecologic oncology · 2021Review
- A 70-Gene Signature for Predicting Treatment Outcome in Advanced-Stage Cervical Cancer.Molecular therapy oncolytics · 2020Article
- Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.International journal of cancer · 2020Review
- Cervical cancer outcome by type of health care facilities: National Cancer Database, 2004-2015.Cancer health disparities · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveEvaluate the characteristics and screening history of patients diagnosed with cervical cancer over age 65.
methodsA retrospective review of 34 patients who were diagnosed with cervical cancer after the age of 65 at a single community cancer center between 2006 and 2016 was performed. Data collected included screening history, method of detection, stage, and survival.
resultsBetween 2006 and 2016, 346 women were diagnosed with cervical cancer at a single community cancer center, 34 (9.8%) of them were over 65 years old. 30 had known screening histories and could be evaluated. 15 women had adequate screening prior to being diagnosed with cervical cancer, indicating that 50% of women who developed cervical cancer after age 65 in this population followed screening guidelines and still developed disease.
conclusionsWomen over 65 make up a significant portion of women diagnosed with cervical cancer. As many as half of all cervical cancers over age 65 occur in women who get recommended screening, and some of these may be prevented or detected early if screening was extended beyond age 65.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.